Myopathy in Metabolic Bone Disease
نویسندگان
چکیده
منابع مشابه
Metabolic Bone Disease in Very Low-Birth-Weight Neonates
Background: Metabolic bone diseases (MBD), including rickets and osteopenia, are important neonatal complications among preterm infants. This study aimed to determine the prevalence and risk factors of MBD in neonates with very low birth weight (VLBW). Methods: This prospective study was conducted on VLBW infants from January 2012 to July 2013. Inclusion criteria were birth weight of ≤1500 g a...
متن کاملMetabolic myopathy.
RECENT years have witnessed a considerably increased interest in disorders of muscle, resulting in large measure from the advent of new investigative techniques. This has led both to the clarification of the nature of known disorders and to the definition of new syndromes. In this review, a brief survey is given of current knowledge concerning myopathic disorders arising from metabolic disturba...
متن کاملMitochondrial Bioenergetics in the Metabolic Myopathy Accompanying Peripheral Artery Disease
Peripheral artery disease (PAD) is a serious but relatively underdiagnosed and undertreated clinical condition associated with a marked reduction in functional capacity and a heightened risk of morbidity and mortality. The pathophysiology of lower extremity PAD is complex, and extends beyond the atherosclerotic arterial occlusion and subsequent mismatch between oxygen demand and delivery to ske...
متن کاملMetabolic bone disease in chronic kidney disease.
Metabolic bone disease is a common complication of chronic kidney disease (CKD) and is part of a broad spectrum of disorders of mineral metabolism that occur in this clinical setting and result in both skeletal and extraskeletal consequences. Detailed research in that past 4 decades has uncovered many of the mechanisms that are involved in the initiation and maintenance of the disturbances of b...
متن کاملMetabolic Bone Disease in Inflammatory Bowel Disease.
An oral calcium supplement (1000 mg/day) is recommended. Regular exercise should be performed. Ethanol intake should be moderate. Protein intake should be moderate. The patient's vitamin D status should be determined and corrected with an oral supplement when deficiency is present. Baseline and yearly bone density measurement should be taken. Alendronate, 10 mg/d orally, or risedronate, 5 mg/d ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 1965
ISSN: 0959-8138,1468-5833
DOI: 10.1136/bmj.1.5451.1670-b